Clinical Trial

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

Study acronym: VITAL
Recruiting
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-02-05; most recent amendment 2026-04-21.
Trial Details
NCT Number NCT07407894
Lead Sponsor Synbiotic Health
Collaborators: MusB Research
Conditions Healthy Aging, Anti Aging
Enrollment 80 participants
Start Date 2026-02-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-22